VERILOID Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
When do Veriloid patents expire, and what generic alternatives are available?
Veriloid is a drug marketed by 3M and is included in one NDA.
The generic ingredient in VERILOID is alkavervir. Additional details are available on the alkavervir profile page.
Summary for VERILOID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Patent Applications: | 272 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | VERILOID at DailyMed |
US Patents and Regulatory Information for VERILOID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | VERILOID | alkavervir | TABLET;ORAL | 007336-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| 3m | VERILOID | alkavervir | TABLET;ORAL | 007336-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
